Cite
HARVARD Citation
Benderradji, H. et al. (2022). Efficacy of lanreotide 120 mg primary therapy on tumour shrinkage and ophthalmologic symptoms in acromegaly after 1 month. Clinical endocrinology. pp. 52-63. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Benderradji, H. et al. (2022). Efficacy of lanreotide 120 mg primary therapy on tumour shrinkage and ophthalmologic symptoms in acromegaly after 1 month. Clinical endocrinology. pp. 52-63. [Online].